First, treatment of an EphA4 inhibitor Cpd1 did not neutralize the tumor regression induced by RNase1 overexpression and Cpd1 treatment only could repress 4T1 tumor growth in the Figure 1 of this previous study. The gene discussed is EPHA4; the disease is neoplasm.